T cell lymphoblastic lymphoma (T-LBL) is a common variant of Non-Hodgkin's tumor of mediastinum which presents late due to aggressive spread. Immunohistochemical studies are conclusive in their diagnosis. We present a rare case of mediastinal tumor with left breast mass which mimicked thymoma on computed tomography guided biopsy but was diagnosed T-LBL on immunohistochemistry after surgical excision.
INTRODUCTION
Lymphoblastic lymphoma (LBL) compromise 2% of all types of non-Hodgkin's lymphoma (NHL). The T-cell phenotype accounts for 80-90% of cases, which arises from immature T-cells. 1 T cell lymphoblastic lymphoma (T-LBL) presents with primary involvement of thymus, nodal or extra nodal. It is aggressive and progresses rapidly, presenting as stage IV disease in more than 70%. Immunohistochemistry (IHC) studies of the tissue is diagnostic in these cases. Chemotherapy is the main treatment in T-LBL type of NHL.
CASE REPORT
A 34-year-old female suspected to have tubercular effusion (which was not subsiding with intercostal tube drainage of more than one week) was referred for further management. Patient was diagnosed with fibrocystic disease of left breast lump prior to these episodes of massive pleural effusion. Patient had developed low pitch of voice with dysphagia over one week. Blood investigations were normal. CT thorax revealed large lobular heterogeneous patchily enhancing soft tissue attenuated mass across the anterior mediastinal/pre vascular space with associated pericardial invasion, bilateral pleural effusion and bilateral mammary medial quadrant lobulations ( Figure 1 ).
Figure 1: CT thorax thorax revealed large lobular heterogeneous patchily enhancing soft tissue attenuated mass across the anterior mediastinal/pre vascular space with associated pericardial invasion, bilateral pleural effusion and bilateral mammary medial quadrant lobulations.
CT guided biopsy suggestive of type B1 thymoma. Hence patient posted for resection. On operating table dirty greyish mass, rubbery in consistency was found adherent to under surface of sternum, also invaded the anterior pericardium and bilateral pleura. Small multiple similar consistency, dirty greyish nodules seen over the lower lobe lungs and diaphragm. The mass in the left breast was of soft to firm consistency, whitish, 4×3 cms. (Figure 2 ) tumor debulking done along with anterior pericardium and sent for HPE, which gave definitive diagnosis of NHL lymphoblastic lymphoma T-cell type (both the mediastinal and breast mass). Patient was given COP regime and endoxan. Patient worsened further. PET scan done revealed disease spread to bilateral pleura, D10, D11, D12, left breast and axillary lymphnode. Patient succumbed to disease after 1 month from surgery. 
DISCUSSION
In NHL, 2% are of lymphoblastic type with the T-cell phenotype accounting for 80-90% of cases, which arises from immature T-cells. 1 It primary involves of thymus, nodal or extra nodal. It is aggressive and progresses rapidly, presenting as stage IV disease in more than 70%. It predominates in young adults and adolescents with median age of diagnosis of 20years and slight male predominance. 2 T-LBL of mediastinum is rapidly growing with respiratory impairment and pleural effusion being common presentation. 3 The 5 year survival is 45-55% in adults. 3 Poor prognosis when age >30-40 yrs, increased levels of LDH (more than 1.5 times normal), involvement of brain, spinal cord, bone marrow and extranodal, stage IV and presence of constitutional symptoms and anemia. 4 Diagnosis is mainly by biopsy with IHC studies. Treatment mainly involves chemotherapy, the various regimes are CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) and hyper-CVAD (fractionated cyclophosphamide, vincristine, adriamycin and dexamethasone). [5] [6] [7] [8] [9] [10] [11] Despite the initial remission rates of 40-60%, there is relapse. In our case, the T cell lymphoblastic lymphoma had involved breast, which is almost not seen in T-LBL. Literature search did not yield any such case report with T cell lymphoblastic lymphoma spread to breast.
CONCLUSION
T-LBL of NHL is a common tumor seen arising in the thymus and extra nodal tissue. They present in late stage (stage IV) which gives poor prognosis. The other tumors like thymoma may mimic causing dilemma in treatment or failure of treatment. Immunohistochemistry studies are definitive in diagnosis. Our case was of aggressive lymphoblastic lymphoma of thymus, which was mimicking thymoma, (as given by CT biopsy) which has a better prognosis with surgical excision and radiotherapy. The lesion had spread to breast which is a very rare occurrence. T-lymphoblastic lymphoma has to be treated with chemotherapy and surgery to be avoided. Pitfall in differentiating thymic lymphoma and Thymomas occurs due to presence of reactive Tlymphocytosis in both conditions and also due to almost identical immunotype and morphology of lymphocytes.
The main distinguishing feature is mainly in infiltrative nature of T-LBL, no or few keratin positive cells with clonal TCR rearrangement histologically.
